The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Open accessAbstract
Summary Germline mutations of BRCA1 predispose women to breast and ovarian cancers. However, the downstream mediators of BRCA1 function in tumor suppression remain elusive. We found that human BRCA1-associated breast cancers have lower levels of SIRT1 than their normal controls. We further demonstrated that mammary tumors from BRCA1 mutant mice have low levels of SIRT1 and high levels of Survivin, which is reversed by induced expression of BRCA1. BRCA1 binds to the SIRT1 promoter and increases SIRT1 expression, which in turn inhibits Survivin by changing the epigenetic modification of histone H3. Absence of SIRT1 blocks the regulation of Survivin by BRCA1. Furthermore, we demonstrated that activation of SIRT1 and inhibition of Survivin expression by resveratrol elicit a more profound inhibitory effect on BRCA1-mutant cancer cells than on BRCA1-wild type cancer cells both in vitro and in vivo. These findings suggest that resveratrol treatment serves as an excellent strategy for targeted therapy for BRCA1-associated breast cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase
Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., Tran, H., Ross, S. E., Mostoslavsky, R., Cohen, H. Y., et al. (2004) · Science · doi:10.1126/science.1094637 · Cited by 3,239
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., et al. (1998) · The American Journal of Human Genetics · doi:10.1086/301749 · Cited by 3,037
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
The Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,395
Mammalian SIRT1 Represses Forkhead Transcription Factors
Motta, M. C., Divecha, N., Lemieux, M., Kamel, C., Chen, D., Gu, W., Bultsma, Y., McBurney, M., & Guarente, L. (2004) · Cell · doi:10.1016/s0092-8674(04)00126-6 · Cited by 1,357
Mammalian sirtuins—emerging roles in physiology, aging, and calorie restriction
Haigis, M. C., & Guarente, L. P. (2006) · Genes & Development · doi:10.1101/gad.1467506 · Cited by 1,295
Survivin, cancer networks and pathway-directed drug discovery
Altieri, D. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2293 · Cited by 994
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53
Hoffman, W. H., Biade, S., Zilfou, J. T., Chen, J., & Murphy, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106643200 · Cited by 794
Impaired DNA Damage Response, Genome Instability, and Tumorigenesis in SIRT1 Mutant Mice
Wang, R.-H., Sengupta, K., Li, C., Kim, H.-S., Cao, L., Xiao, C., Kim, S., Xu, X., Zheng, Y., Chilton, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.09.001 · Cited by 769
Self-citationXu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Self-citationSir2 links chromatin silencing, metabolism, and aging
Guarente, L. (2000) · Genes & Development · doi:10.1101/gad.14.9.1021 · Cited by 716
Nutrient Availability Regulates SIRT1 Through a Forkhead-Dependent Pathway
Nemoto, S., Fergusson, M. M., & Finkel, T. (2004) · Science · doi:10.1126/science.1101731 · Cited by 677
Self-citationTumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses
Chen, W. Y., Wang, D. H., Yen, R. C., Luo, J., Gu, W., & Baylin, S. B. (2005) · Cell · doi:10.1016/j.cell.2005.08.011 · Cited by 648
Self-citationThe SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth.
Firestein, R., Blander, G., Michan, S., Oberdoerffer, P., Ogino, S., Campbell, J., Bhimavarapu, A., Luikenhuis, S., de Cabo, R., Fuchs, C., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002020 · Cited by 588
BRCA1: cell cycle checkpoint, genetic instability, DNA damage response and cancer evolution
Deng, C.-X. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl010 · Cited by 584
Self-citationInduction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
Harkin, D. P., Bean, J. M., Miklos, D., Song, Y.-H., Truong, V. B., Englert, C., Christians, F. C., Ellisen, L. W., Maheswaran, S., Oliner, J. D., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80769-2 · Cited by 557
Increase in Activity During Calorie Restriction Requires Sirt1
Chen, D., Steele, A. D., Lindquist, S., & Guarente, L. (2005) · Science · doi:10.1126/science.1118357 · Cited by 419
Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer
Delmas, D., Lancon, A., Colin, D., Jannin, B., & Latruffe, N. (2006) · Current Drug Targets · doi:10.2174/138945006776359331 · Cited by 395
Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001) · Nature Genetics · doi:10.1038/90108 · Cited by 373
Self-citationSurvivin is required for a sustained spindle checkpoint arrest in response to lack of tension
Lens, S. M. A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg307 · Cited by 310
Estrov, Z., Shishodia, S., Faderl, S., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Aggarwal, B. B. (2003) · Blood · doi:10.1182/blood-2002-11-3550 · Cited by 306
Cao, L., Li, W., Kim, S., Brodie, S. G., & Deng, C.-X. (2003) · Genes & Development · doi:10.1101/gad.1050003 · Cited by 293
Self-citationThe molecular biology of the SIR proteins
Gasser, S. M., & Cockell, M. M. (2001) · Gene · doi:10.1016/s0378-1119(01)00741-7 · Cited by 266
Survivin as a target for new anticancer interventions
Zaffaroni, N., Pannati, M., & Diadone, M. G. (2005) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2005.tb00361.x · Cited by 244
The Role of the BRCA1 Tumor Suppressor in DNA Double-Strand Break Repair
Zhang, J., & Powell, S. N. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-05-0192 · Cited by 209
Linking chromatin function with metabolic networks: Sir2 family of NAD+-dependent deacetylases
Denu, J. M. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00005-1 · Cited by 208
Sir2 Regulates Histone H3 Lysine 9 Methylation and Heterochromatin Assembly in Fission Yeast
Shankaranarayana, G. D., Motamedi, M. R., Moazed, D., & Grewal, S. I. S. (2003) · Current Biology · doi:10.1016/s0960-9822(03)00489-5 · Cited by 202
Brodie, S. G., Xu, X., Qiao, W., Li, W.-M., Cao, L., & Deng, C.-X. (2001) · Oncogene · doi:10.1038/sj.onc.1204929 · Cited by 188
Self-citationXia, W., Bisi, J., Strum, J. C., Liu, L.-H., Carrick, K., Graham, K. M., Treece, A. L., Hardwicke, M. A., Dush, M. K., Liao, Q., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2000 · Cited by 165
A requirement for breast-cancer-associated gene 1 (BRCA1) in the spindle checkpoint
Wang, R.-H., Yu, H., & Deng, C.-X. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407585101 · Cited by 163
Self-citationAziz, M. H., Afaq, F., & Ahmad, N. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-08-13-ra-274.1 · Cited by 159
Cao, L., Kim, S., Xiao, C., Wang, R., Coumoul, X., Wang, X., Li, W. M., Xu, X. L., Soto, J. A. D., Takai, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601115 · Cited by 157
Self-citationKawakami, H., Tomita, M., Matsuda, T., Ohta, T., Tanaka, Y., Fujii, M., Hatano, M., Tokuhisa, T., & Mori, N. (2005) · International Journal of Cancer · doi:10.1002/ijc.20954 · Cited by 148
Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.
Whitsett, T. G., Carpenter, M., & Lamartiniere, C. A. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-15 · Cited by 137
Tumorigenesis in mice carrying a truncating Brca1 mutationPreprint
Ludwig, T. G., Fisher, P. E., Ganesan, S., & Efstratiadis, A. (2001) · Genes & Development · doi:10.1101/gad.879201 · Cited by 130
Roles of BRCA1 in centrosome duplication
Deng, C. (2002) · Oncogene · doi:10.1038/sj.onc.1205713 · Cited by 120
Self-citationEpidemiology, prevention, and early detection of breast cancer
Daudt, A. W., Alberg, A. J., & Helzlsouer, K. J. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199611000-00003 · Cited by 116
Cancer-specific activation of the survivin promoter and its potential use in gene therapy
Chen, J., Liu, J.-C., Shen, L., Rau, K.-M., Kuo, H.-P., Li, Y. M., Shi, D., Lee, Y.-C., Chang, K., & Hung, M. (2004) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700752 · Cited by 115
Self-citationHsieh, T. ‐., & WU, J. M. (2000) · PubMed · Cited by 76
Tominaga, Y., Wang, A., Wang, R.-H., Wang, X., Cao, L., & Deng, C.-X. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402037 · Cited by 56
Self-citationCao, L., Xu, X., Cao, L. L., Wang, R., Coumoul, X., Kim, S. S., & Deng, C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm060 · Cited by 54
Self-citationEpidemiology, prevention, and early detection of breast cancer
Alberg, A. J., Lam, A. P., & Helzlsouer, K. J. (1999) · Current Opinion in Oncology · doi:10.1097/00001622-199911000-00003 · Cited by 50
Shukla, V., Coumoul, X., Cao, L., Wang, R.-H., Xiao, C., Xu, X., Andò, S., Yakar, S., LeRoith, D., & Deng, C. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4570 · Cited by 49
Self-citationFamilial non-BRCA1/BRCA2-associated breast cancer
Eccles, D., & Pichert, G. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70318-1 · Cited by 38
Simeone, A., Deng, C., Kelloff, G. J., Steele, V. E., Johnson, M. M., & Tari, A. M. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi038 · Cited by 27
Self-citation
Cited by
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
Recent progress in the biology and physiology of sirtuins
Finkel, T., Deng, C.-X., & Mostoslavsky, R. (2009) · Nature · doi:10.1038/nature08197 · Cited by 1,484
Self-citationRegulation of SIRT1 in cellular functions: Role of polyphenols
Chung, S., Yao, H., Caito, S., Hwang, J.-W., Arunachalam, G., & Rahman, I. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.05.003 · Cited by 650
The NAD metabolome — a key determinant of cancer cell biology
Chiarugi, A., Dölle, C., Felici, R., & Ziegler, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3340 · Cited by 639
The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance
Bouwman, P., & Jonkers, J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3342 · Cited by 615
Metadata
- Authors
- Wang, R.-H., Zheng, Y., Kim, H.-S., Xu, X., Cao, L., Lahusen, T., Lee, M.-H., Xiao, C., Vassilopoulos, A., Chen, W., Gardner, K., Man, Y.-G., Hung, M.-C., Finkel, T., & Deng, C.-X.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2008-10
- Volume
- 32
- Issue
- 1
- Pages
- 11-20
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2034591470
- Cited by
- 359
- References
- 52
- FWCI
- 12.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.